Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer
J Orcajo-Rincon, J Muñoz-Langa… - Clinical and …, 2022 - Springer
Bone metastases are very common complications associated with certain types of cancers
that frequently negatively impact the quality of life and functional status of patients; thus …
that frequently negatively impact the quality of life and functional status of patients; thus …
A Comprehensive Review of Interventional Clinical Trials in Patients with Bone Metastases
F Shen, J Huang, K Yang, C Sun - OncoTargets and Therapy, 2023 - Taylor & Francis
Bone metastasis is one of the most important factors associated with poor prognosis for
patients with prostate, breast, thyroid, and lung cancer. In the past two decades, 651 clinical …
patients with prostate, breast, thyroid, and lung cancer. In the past two decades, 651 clinical …
Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health …
A Seesaghur, P Egger, J Warden, A Abbasi, B Levick… - BMJ open, 2023 - bmjopen.bmj.com
Objective To assess use of bone-targeting agents (BTA) in patients with confirmed bone
metastases (BM) from breast cancer (BC), non-small cell lung cancer (NSCLC) or prostate …
metastases (BM) from breast cancer (BC), non-small cell lung cancer (NSCLC) or prostate …
Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone …
H Zhao, G Pond, D Simos, Z Wang, S Robertson… - Cancers, 2023 - mdpi.com
Simple Summary The current study was a retrospective exploratory study evaluating
whether circulating levels of known targets of doxycycline were altered following …
whether circulating levels of known targets of doxycycline were altered following …
Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer
WJ Phillips, F Saad, J Leigh, A Jooya, C Webber… - The …, 2024 - academic.oup.com
Introduction Anti-osteoclast treatment with denosumab or zoledronate is known to effectively
reduce the need for radiotherapy to bone and other skeletal-related events (SREs) in …
reduce the need for radiotherapy to bone and other skeletal-related events (SREs) in …
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription …
V Fusco, M Di Maio, AA Valsecchi, D Santini… - Supportive Care in …, 2024 - Springer
Purpose Optimal use of bone-modifying agents (BMAs) in patients with bone metastases
from solid tumors is uncertain in some aspects: the drug choice; the planned treatment …
from solid tumors is uncertain in some aspects: the drug choice; the planned treatment …
Comprehensive Clinical Literature Review of Managing Bone Metastases in Breast Cancer: Focus on Pain and Skeletal-Related Events.
K Hamash, SL Walker - Clinical Journal of Oncology Nursing, 2023 - search.ebscohost.com
BACKGROUND: Bone metastases are the most common site of metastatic disease in breast
cancer and can result in significant pain and an increased risk of skeletal-related events …
cancer and can result in significant pain and an increased risk of skeletal-related events …
Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study
IJ Diel, R Greil, J Janssen, CW Kluike, B Behera… - Supportive Care in …, 2022 - Springer
Purpose To describe (non) adherence with denosumab among patients with solid tumors
and bone metastases. Methods This retrospective, observational study pooled data from two …
and bone metastases. Methods This retrospective, observational study pooled data from two …
ОБЗОР МЕТОДОВ ВИЗУАЛИЗАЦИИ ДЛЯ ОЦЕНКИ ОТВЕТА НА ЛЕЧЕНИЕ МЕТАСТАЗОВ В КОСТИ ПРИ РАКЕ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ И МОЛОЧНОЙ …
ЕА Николаева, ЕВ Тарачкова… - Кремлевская …, 2022 - kremlin-medicine.ru
Аннотация Костные метастазы являются крайне частыми осложнениями, связанными с
некоторыми видами рака, часто негативно влияющими на качество жизни и …
некоторыми видами рака, часто негативно влияющими на качество жизни и …
[引用][C] Anouchka Seesaghur, Peter Egger, 2 Joshua Warden, 2 Ali Abbasi, Bethany Levick, 2 Majid Riaz, 2 Peter McMahon, 2 Matthew Thompson, 2
S Cheeseman - europepmc.org
Objective To assess use of bone-targeting agents (BTA) in patients with confirmed bone
metastases (BM) from breast cancer (BC), non-small cell lung cancer (NSCLC) or prostate …
metastases (BM) from breast cancer (BC), non-small cell lung cancer (NSCLC) or prostate …